Hi Koo,

Just for fun and games, assuming $1.37 is now the market price for Zenith capital corp shares, with about a 160 Million shares outstanding that puts the enterprise value at around $225 million Cad.

Now if a  BP buyout or staged /milestone buyout (more likely)were to occur in the next few years or less lets use a  multiple of 7 or 8 times to come up with a buyout price . This is worst case scenario low ball based on how pathetic DM is at CEO  in most likely negotiation , thus putting a buyout price at $1.8 Billion Cad, or $11 approximate.  Now based on so far the clinical results from Zen3694 which seem promising. Pfizer $14 Billion  buyout of medivation in 2016 makes Zenith $1.8 Billion look like unbelievable steal by any pharma.  I will take $11 at this point as it free money from the spinoff shares and will make up for  my RVX investment which is not moving forward at this point.  I think we may have a winner in Zenith it just might take some years for clinical trials to get there. 

As for ZHCLF shares at .16,  i think it is extremely difficult to buy shares and would be impossible to buy huge lots. I bought  4000 shares and it it took me 1 week  to  fill at the ask . good luck if i had sell them on the expert market. I will wait for a buyout....